HB 4131
Plain-language analysis
Generated analysis, not an official summary or legal advice. Confirm with linked Oregon documents.
HB 4131 creates a new mobile pharmacy license under Oregon law, authorizing eligible health entities to operate mobile prescription units subject to strict operational, storage, recordkeeping, and location limits. The measure expands healthcare delivery access while imposing new regulatory oversight and compliance obligations on operators and the State Board of Pharmacy, with full implementation beginning January 2027.
Basis: Bill text · Source: Enrolled
Official sources do not state why this measure was proposed.
Sponsor testimony, staff summaries, committee materials, or statutory findings may explain it.
Inferred from cited text; not a stated purpose.
The legislature likely aims to formalize mobile pharmacy deployments to improve medication access in underserved or geographically isolated areas while establishing clear diversion-prevention and continuity-of-care safeguards.
Basis: Inferred · Source: Enrolled
Gains statutory authority to apply for a mobile pharmacy license and deploy prescription services outside fixed locations, subject to board rules and licensure fees.
Basis: Bill text · Source: Enrolled
Assumes new licensing, rulemaking, inspection, and oversight responsibilities; collects fees deposited into the State Board of Pharmacy Account.
Basis: Bill text · Source: Enrolled
May gain expanded access to prescription refills and mobile care, but must rely on mandated communication plans for refill continuity when units are unavailable.
Basis: Bill text · Source: Enrolled
Receives mandated communication plans from mobile pharmacies to ensure compliance with local communicable disease reporting requirements.
Basis: Bill text · Source: Enrolled
Operators must maintain a physically present pharmacist during all hours of operation, sync dispensing records to the permanent outlet within 24 hours, and implement diversion-proof storage compliant with manufacturer guidelines and DEA federal standards.
Basis: Bill text · Source: Enrolled
Deployment is restricted to a maximum of 10 consecutive days at one location or 14 consecutive days within a five-mile radius, though the board may grant exceptions for declared emergencies or natural disasters.
Basis: Bill text · Source: Enrolled
Fees set by the board will fund board implementation, with estimated administrative costs of $98,990 in 2025-27 and $181,754 in 2027-29 for a dedicated specialist position.
Basis: Official analysis · Source: Fiscal Impact Statement INTRO
Displaced populations during a declared disaster
A hospital deploys mobile pharmacies continuously for months within a flood-affected zone under the emergency exception, providing uninterrupted medication access to residents without fixed pharmacy infrastructure.
Basis: Bill text · Source: Enrolled
Operators exploiting location limits
A county rotates mobile units just under the 10-day/5-mile thresholds to avoid fixed-site pharmacy regulations, creating inconsistent care standards and complicating board inspection logistics while technically complying with the text.
Basis: Bill text · Source: Enrolled
The text legally permits operational flexibility but relies on board rules and inspections to prevent duty creep or regulatory arbitrage. Without robust audit trails and consistent oversight, entities could exploit location limits or storage exemptions while claiming compliance.
Sources · Enrolled
Expanding mobile pharmacy access improves geographic and temporal healthcare delivery but increases regulatory complexity, oversight costs, and potential for operational fragmentation or diversion risks if compliance monitoring is inconsistent.
Enhanced patient access to prescriptions in underserved areas; improved emergency response resilience; integrated care coordination with mobile dental and public health services.
Basis: Bill text · Source: Enrolled
Administrative burden on the Board of Pharmacy; risk of regulatory gaps in drug security; potential strain on local public health reporting systems if communication plans are poorly implemented.
Basis: Bill text · Source: Enrolled
The enrolled version establishes a complete statutory framework with explicit operational mandates (pharmacist presence, record synchronization, storage standards, communication plans), precise location/time limits (10 days/location, 14 days/5-mile radius), emergency exceptions, co-location permissions, fee deposit specifications, and operative dates. The previous version was a draft amendment list that primarily adjusted subsection numbering without altering substantive policy direction. The enrolled text finalizes the regulatory structure and adds enforcement-ready provisions absent in the earlier draft.
Formalized eligible entities (critical access pharmacies, hospitals, FQHCs, county governing bodies) and permanent location requirement.
Narrows licensure to established health infrastructure, reducing unregulated mobile operations.
Sources · Enrolled
Tradeoff: Increased regulatory clarity and oversight capacity versus reduced flexibility for non-traditional or independent mobile pharmacy operators.
high confidence. The enrolled bill text provides explicit statutory mandates, eligibility criteria, operational limits, and funding mechanisms. Fiscal impacts are documented by the Legislative Fiscal Office. Remaining uncertainties depend on future board rulemaking.
Possible effects if adopted; not current bill text.
The amendment deletes the statutory mandate requiring the Oregon Board of Pharmacy to issue mobile pharmacy licenses within 60 days of application. If adopted, it eliminates a fixed processing deadline, giving the board administrative flexibility but removing a guaranteed timeline for applicants seeking licensure.
Basis: Bill text · Sources: Amendment -1 — proposed amendment; Staff Measure Summary A
Official sources do not state why this measure was proposed.
Sponsor testimony, staff summaries, committee materials, or statutory findings may explain it.
Inferred from cited text; not a stated purpose.
The board may have requested removal of the 60-day deadline due to anticipated rulemaking complexity or staffing constraints, as fiscal analysis notes workload will depend on future rulemaking and existing vacancy savings may be insufficient.
Basis: Inferred · Sources: Staff Measure Summary A; Fiscal Impact Statement A
Gains scheduling flexibility for license processing but loses a statutory deadline that could have driven internal prioritization.
Basis: Bill text · Source: Introduced
Lose the guaranteed 60-day licensing timeline; processing times become subject to board capacity and rulemaking pace.
Basis: Bill text · Source: Introduced
Face potential delays in accessing mobile pharmacy services if licensure bottlenecks occur without a statutory deadline.
Basis: Inferred · Source: Fiscal Impact Statement A
OBOP can prioritize other regulatory work or manage licensing queues based on actual rulemaking completion rather than a rigid calendar.
Basis: Bill text · Source: Introduced
Applicants may experience unpredictable wait times, potentially delaying service deployment to rural or underserved areas.
Basis: Inferred · Source: Fiscal Impact Statement A
The board retains authority to set fees and operational rules, but fee adoption remains subject to legislative approval under ORS 291.050 and ORS 291.055.
Basis: Bill text · Source: Fiscal Impact Statement INTRO
Regulatory oversight
OBOP successfully uses the flexibility to align licensing with comprehensive rulemaking, avoiding rushed approvals that could compromise drug safety or diversion prevention standards.
Basis: Bill text · Source: Introduced
Public health access
The board faces prolonged backlogs due to competing priorities or insufficient staffing, leaving eligible applicants unlicensed for over a year and stalling mobile pharmacy deployment in areas with documented pharmacy deserts.
Basis: Inferred · Source: Fiscal Impact Statement A
The amendment removes a statutory timeline but does not grant authority to deny qualified applicants or impose quotas. Duty creep could occur if the board treats processing delays as implicit denials without formal rulemaking or due process.
Sources · Introduced; Fiscal Impact Statement A
The amendment trades a guaranteed licensing timeline for administrative flexibility, which may improve regulatory thoroughness but risks delaying healthcare access for communities dependent on mobile pharmacy services. Upsides include reduced pressure on board staff and alignment with rulemaking realities; downsides include unpredictable wait times for applicants and potential service gaps in underserved regions.
Reduced administrative pressure allows the board to focus on comprehensive rulemaking and inspection protocols before processing applications.
Basis: Inferred · Source: Fiscal Impact Statement A
Alignment of licensing timelines with actual rulemaking completion prevents premature or inconsistent approvals.
Basis: Bill text · Source: Introduced
Applicants face unpredictable wait times, potentially delaying service deployment to rural or underserved areas.
Basis: Inferred · Source: Fiscal Impact Statement A
Loss of a statutory deadline removes a measurable accountability mechanism for board performance.
Basis: Bill text · Source: Amendment -1 — proposed amendment
high confidence. The amendment's mechanical effect is explicitly documented in committee staff summaries and aligns with the introduced bill text. Fiscal impacts are clearly delineated, though workload projections remain indeterminate pending rulemaking.
39 records currently loaded
Records available in the current snapshot.
Earliest loaded signal
Introduced bill text posted
Posted Jan 28, 2026, 3:25 PM PST
Follow the official text for HB 4131 and every amendment branch. Connections come from each amendment's stated base. Horizontal position shows when each document was first posted, when available.
Click a card to isolate its connected lines; use View summary to jump to its details. Horizontal position shows first posting time in Pacific Time. Drag or use the arrow keys to pan. Pinch with two fingers on mobile, or zoom with the controls, +/− keys, or Control/Command + scroll; press 0 to reset. Dashed branches remained proposals.
Selected document summary
Targeted changes
What the document says to change
On page 2 of the printed bill, delete lines 18 and 19.
Official records (1)
No deeper official pre-number history was found.
Chief sponsors: Representative Hai Pham, Representative Rob Nosse, Representative Sue Rieke Smith, Senator Deb Patterson
Regular sponsors: Representative Tom Andersen, Representative Mark Gamba, Representative David Gomberg, Representative Darin Harbick, Representative Annessa Hartman, Representative Shannon Isadore, Representative Bobby Levy, Representative Sarah McDonald, Representative Lesly Muñoz, Representative Travis Nelson, Representative Kim Wallan, Representative Mari Watanabe, Representative Lamar Wise, Senator Wlnsvey Campos, Senator Lew Frederick, Senator Jeff Golden, Senator Mark Meek, Senator Courtney Neron Misslin, Senator Lisa Reynolds, Senator David Brock Smith, Senator Janeen Sollman, Senator Suzanne Weber, Representative Emily McIntire, Representative Cyrus Javadi
House carrier
Representative Ricki Ruiz
Third Reading Of House Bills · Version A
Senate carrier
Senator Lew Frederick
Third Reading Of House Measures · Version A
A carrier presents the measure or report but is not necessarily its sponsor or author.
Records already listed in Activity are not repeated here.
Official origin records are incomplete; missing facts are not inferred.
39 events
Full timeline
39 entries shown.
Chapter 116, (2026 Laws): Effective date June 5, 2026.
Governor signed.
President signed.
Speaker signed.
Third reading. Carried by Frederick. Passed.
Ayes, 30.
Second reading.
Recommendation: Do pass the A-Eng. bill.
Staff Measure Summary · Version A
Referred to Ways and Means.
First reading. Referred to President's desk.
Third reading. Carried by Ruiz. Passed.
Ayes, 41; Excused, 17--Boshart Davis, Diehl, Edwards, Helfrich, Javadi, Lewis, Mannix, McIntire, Nelson, Osborne, Pham H, Reschke, Skarlatos, Tran, Valderrama, Wright, Yunker; Excused for Business of the House, 2--Fragala, Hartman.
Second reading.
Recommendation: Do pass.
Work Session held.
Work Session
Heard and Reported Out · Agenda item 6 · Room HR 40 · Relating to mobile pharmacies; prescribing an effective date (Representative Ruiz, carrier)
Returned to Full Committee.
Work Session held.
Work Session
Heard and Reported Out · Agenda item 3 · Room HR G · Relating to mobile pharmacies; prescribing an effective date
Assigned to Subcommittee On Education.
House Amendments to Introduced bill text posted
Referred to Ways and Means by order of Speaker.
Recommendation: Do pass with amendments, be printed A-Engrossed, and be referred to Ways and Means.
Work Session held.
Work Session
Heard and Reported Out with Amendments · Agenda item 6 · Room HR 60 · Directs the State Board of Pharmacy to issue a license to operate a mobile pharmacy to a qualified applicant.
IS_Impact HB 4131 1
Revenue Impact Statement
Amendment -1 adopted
Public Hearing held.
Public Hearing
Heard · Agenda item 6 · Room HR 60 · Directs the State Board of Pharmacy to issue a license to operate a mobile pharmacy to a qualified applicant.
Referred to Health Care.
First reading. Referred to Speaker's desk.
sing health care in traditional settings, including time, geography, and trust. House Bill 4052 (2022) directed the Oregon Health Authority (OHA) to convene a committee to pro
sing health care in traditional settings, including time, geography, and trust. House Bill 4052 (2022) directed the Oregon Health Authority (OHA) to convene a committee to pro
sing health care in traditional settings, including time, geography, and trust. House Bill 4052 (2022) directed the Oregon Health Authority (OHA) to convene a committee to pro
“Chapter 116, (2026 Laws): Effective date June 5, 2026.”
Confirm with the official record.
Supplemental, source-linked analysis from project researchers and community contributors. It is separate from Oregon's official record.